Related Experiment Videos
[Studies on meiotic delay and aneuploidies induced by colcemid (COM) in male mouse germ cells]
Abstract:
Colcemid (COM) was tested for induction of meiotic delay and aneuploidies in meiotic metaphase II (MMII) of male(101/E 1 XC 3 H/E 1)F 1 mice post single intraperitoneum (i.p.) injection. The dose of 1 mg/kg of COM was used and sampled at 2, 6, 10, 14 and 18 h after COM treatment. The number of MMII and MMI were the highest at 2 and 6 h repectively, and decreased rapidly with lengthening of COM treatment and reached the lowest at 14 h; then increased. However, the ratio of MMII to MMI was always significantly higher than in solvent control at every sample interval. Under our experimental conditions, COM did not show aneugenicity in male mouse germ cells. The possible mechanisms by which COM caused meiotic delay and reasons that COM did not induce aneuploidy in MMII were discussed.
Insights
Colcemid (COM) induces meiotic delay in male mice but does not cause aneuploidy in germ cells. This study investigated COM
Area of Science:
- Reproductive toxicology
- Cytogenetics
- Mammalian reproductive biology
Context:
- Colcemid (COM) is a known antimitotic agent.
- Aneuploidy is a significant cause of infertility and birth defects.
- Understanding the effects of antimitotic agents on male meiosis is crucial for reproductive risk assessment.
Purpose:
- To investigate the potential of Colcemid (COM) to induce meiotic delay and aneuploidy in male mouse germ cells.
- To determine the dose-dependent and time-course effects of COM on meiosis.
- To elucidate the mechanisms underlying COM-induced meiotic alterations.
Summary:
- Single intraperitoneal injection of 1 mg/kg Colcemid (COM) in male mice induced significant meiotic delay, evidenced by altered ratios of meiotic metaphase II (MMII) to meiosis I (MI) cells.
- Despite causing meiotic delay, COM did not demonstrate aneugenicity, failing to induce aneuploidies in male mouse germ cells under the tested experimental conditions.
- The study discusses potential mechanisms for COM-induced meiotic delay and the absence of aneuploidy induction.
Impact:
- Provides critical data on the reproductive safety of Colcemid in male mammals.
- Contributes to the understanding of mechanisms underlying meiotic delay and aneuploidy induction.
- Informs risk assessment for exposure to antimitotic agents during male gametogenesis.